FinanceInnovationStartups

OurCrowd Founder Transitions to Chairman Role as Platform Expands Global Private Market Access

OurCrowd founder Jon Medved is transitioning to Chairman after building the venture platform to 240,000 global members. The move comes as the company focuses on enhancing community engagement and expanding access to private markets for accredited investors worldwide.

Leadership Transition at Global Investment Platform

OurCrowd, a venture investment platform with over 240,000 registered members across 195 countries and $2.6 billion in commitments, is undergoing a significant leadership change, according to reports. Founder Jon Medved will transition from CEO to Chairman, a move that sources indicate will allow him to focus on expanding the platform’s community-building efforts and global strategy.

HealthcareInnovationPolicy

Venture Capital Leader Advocates for Insurance Coverage of Longevity Treatments

The CEO of venture firm General Catalyst is pushing for health insurance to cover longevity treatments, stating the current system prioritizes expensive hospital care over preventive health. Silicon Valley’s tech elite are increasingly investing in anti-aging research and personal health optimization. Insurance companies reportedly remain hesitant due to uncertain return on investment for longevity interventions.

VC Leader Calls for Insurance Reimbursement of Longevity Care

The CEO of global venture capital firm General Catalyst has advocated for health insurance to cover longevity treatments and preventive health measures, according to recent podcast comments. Hemant Taneja stated during an appearance on the “TPBN” podcast that the healthcare system needs to shift toward incentives that keep people healthy rather than focusing primarily on hospital care.

HealthcareInnovation

Revolutionary Retinal Implant Restores Reading Ability for Blind Patients in Clinical Trial

A groundbreaking retinal implant has enabled blind patients to regain reading ability in what surgeons describe as “astounding” results. The microchip technology offers new hope for those suffering from advanced macular degeneration.

Medical Breakthrough for Vision Loss

Blind patients have regained the ability to read through a revolutionary implant positioned at the back of the eye, according to reports from an international clinical trial. Surgeons at Moorfields Eye Hospital in London have inserted the microchips in five patients, with results that sources indicate are transforming lives affected by severe visual impairment.